arrow
返回
H

Hiroyoshi Suzuki

Toho University

62H指数
578论文数
1.4W被引数
收录论文 113
发表时间
Evolving Systemic Therapy for Prostate Cancer: Pivotal Clinical Trials, Biomarker-Driven Combinations, and Practical Sequencing in the ARSI–PARP–Radioligand Era
errCancers
IF4.4
err2026-06-17
err0
errOAAI
errTakatoshi Somoto; Takanobu Utsumi; Rino Ikeda; Tatsuharu Sugimoto; Naoki Ishitsuka; Yodai Kadono; Takahide Noro; Yuta Suzuki; Shota Iijima; Yuka Sugizaki; Ryo Oka; Takumi Endo; Naoto Kamiya; Hiroyoshi Suzuki
err分享
err收藏
Imaging Engineering and Artificial Intelligence in Urinary Stone Disease: Low-Dose Computed Tomography, Spectral Technologies, and Predictive Models泌尿结石疾病中的成像工程与人工智能:低剂量计算机断层扫描、光谱技术与预测模型
errEng
IF2.4
err2026-04-11
err0
PREAI
errIijima, Shota; Utsumi, Takanobu; Ikeda, Rino; Ishitsuka, Naoki; Noro, Takahide; Suzuki, Yuta; Sugizaki, Yuka; Somoto, Takatoshi; Oka, Ryo; Endo, Takumi; Kamiya, Naoto; Suzuki, Hiroyoshi
err分享
err收藏
Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications遗传性泌尿系统癌症的精准护理:基因检测、遗传咨询、监测及治疗意义
err2025-12-11
err0
errOAAI
errTakatoshi Somoto; Takanobu Utsumi; Rino Ikeda; Naoki Ishitsuka; Takahide Noro; Yuta Suzuki; Shota Iijima; Yuka Sugizaki; Ryo Oka; Takumi Endo; Naoto Kamiya; Hiroyoshi Suzuki
err分享
err收藏
Development of a Nomogram for Predicting Lymphovascular Invasion at Initial Transurethral Resection of Bladder Tumors基于初次经尿道膀胱肿瘤切除术预测淋巴血管浸润的列线图开发
err2025-12-09
err0
errOAAI
errSomoto, Takatoshi; Utsumi, Takanobu; Ikeda, Rino; Ishitsuka, Naoki; Noro, Takahide; Suzuki, Yuta; Iijima, Shota; Sugizaki, Yuka; Oka, Ryo; Endo, Takumi; Kamiya, Naoto; Hiruta, Nobuyuki; Suzuki, Hiroyoshi
err分享
err收藏
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysisDARolutamide观察性(DAROL)研究:非转移性去势抵抗性前列腺癌患者的预先设定第三次中期分析
err2025-11-01
err0
errOAAI
errEvan Y. Yu; Hiroyoshi Suzuki; Christopher M. Pieczonka; Geoffrey Gotto; Alberto Briganti; Murilo Luz; Declan Murphy; Ryan Malone; Joelle Hamilton; Jonathan E. Chan; Paul Sieber; Robert W. Given; Eva Hellmis; Thomas Kretz; Philipp Spiegelhalder; Antonio Gómez-Caamaño; Yaovi Messan Amela; Xavier Artignan; Hiroji Uemura; Naoki Fujita; Patrick Adorjan; Mercedeh Ghadessi; Frank Verholen; Andrew J. Armstrong
err分享
err收藏
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trial阿贝西利布联合阿比特龙在转移性去势抵抗性前列腺癌患者中的研究(CYCLONE 2):一项随机、双盲、安慰剂对照、Ⅲ期临床试验
err2025-10-27
err0
PREAI
errMatthew Smith; Josep Piulats; Tilman Todenhöfer; Jae-Lyun Lee; José Arranz Arija; Laura Mazilu; Arun Azad; Teresa Alonso-Gordoa; Ursula McGovern; Atish Choudhury; Lisa Horvath; Dingwei Ye; Weiqing Han; Hiroyoshi Suzuki; Hiroji Uemura; Rana McKay; Steven Ades; Aude Fléchon; Christopher Pieczonka; Maria S Fernandes; Maarten Hulstijn; Andrew Lithio; Karim Nacerddine; Neeraj Agarwal
err分享
err收藏
Navigating Therapeutic Landscapes in Urothelial Cancer: From Chemotherapy to Precision Immuno-Oncology在尿路上皮癌中导航治疗景观:从化疗到精准免疫肿瘤学
err2025-10-18
err0
errOAAI
errTakatoshi Somoto; Takanobu Utsumi; Rino Ikeda; Naoki Ishitsuka; Takahide Noro; Yuta Suzuki; Shota Iijima; Yuka Sugizaki; Ryo Oka; Takumi Endo; Naoto Kamiya; Hiroyoshi Suzuki
err分享
err收藏
Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer in Japan: The ARASHI Study雄激素受体信号抑制剂在日本非转移性去势抵抗性前列腺癌中的应用:ARASHI研究
err2025-10-01
err2
errOAAI
errSuzuki, Kazuhiro; Khan, Nasreen; Taguchi, Tomoyuki; Hattori, Kana; Chen, Guifang; Ghadessi, Mercedeh; Constantinovici, Niculae; Quintero, Vanessa; Suzuki, Hiroyoshi
err分享
err收藏
Carbon-Ion Radiotherapy for Prostate Cancer in Patients with a History of Surgery for Benign Prostatic Hyperplasia碳离子放射治疗在良性前列腺增生手术史患者中的前列腺癌应用
err2025-09-23
err0
errOAAI
errAtsushi Okato; Kosei Miura; Tomoki Yamaguchi; Mio Nakajima; Hirokazu Makishima; Takanobu Utsumi; Koichiro Akakura; Hiroyoshi Suzuki; Masaru Wakatsuki; Hiroshi Tsuji; Tomohiko Ichikawa; Hitoshi Ishikawa
err分享
err收藏
Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate CancerKEYLYNK-010研究中患者报告结局:帕博利珠单抗联合奥拉帕利与阿比特龙或恩扎卢胺治疗生物标志物未筛选、既往接受过治疗的转移性去势抵抗性前列腺癌患者
err2025-07-19
err0
errOAAI
errNiven Mehra; Emmanuel S. Antonarakis; Se Hoon Park; Jeffrey C. Goh; Ray McDermott; Nuria Sala Gonzalez; Peter C. Fong; Richard Greil; Maria De Santis; Patricio Eduardo Yanez; Yi-Hsiu Huang; Stephen D. Begbie; Felipe Rey; Gero Kramer; Hiroyoshi Suzuki; Todd L. Saretsky; Sameer R. Ghate; Yi Cui; Christian Hosius; Evan Y. Yu
err分享
err收藏
Predicting Urosepsis in Ureteral Calculi: External Validation of Hu's Nomogram and Identification of Novel Risk Factors预测输尿管结石相关尿脓毒症:Hu评分表的对外验证与新风险因素的识别
err2025-04-26
err0
errOAAI
errSugizaki, Yuka; Utsumi, Takanobu; Ishitsuka, Naoki; Noro, Takahide; Suzuki, Yuta; Iijima, Shota; Somoto, Takatoshi; Oka, Ryo; Endo, Takumi; Kamiya, Naoto; Suzuki, Hiroyoshi
err分享
err收藏
GLP-1R status using validated monoclonal antibody in 689 cases of neuroendocrine neoplasm and its correlation with somatostatin receptor scintigraphy, insulin production, and histological grades
err2025-04-01
err0
errOAAI
errWatanabe, Hirofumi; Fujishima, Fumiyoshi; Yamazaki, Yuto; Imamura, Masayuki; Hijioka, Susumu; Hara, Kazuo; Kuwahara, Takamichi; Yatabe, Yasushi; Sakamoto, Kazuhiro; Shiga, Hisashi; Kawaguchi, Tomohiro; Suzuki, Hiroyoshi; Kanbayashi, Yumi; Ohkoshi, Akira; Shimada, Muneaki; Niikawa, Hiromichi; Sato, Mami; Fujio, Atsushi; Masui, Toshihiko; Kasai, Yosuke; Ota, Hideki; Ozawa, Hiroshi; Endo, Hidenori; Unno, Michiaki; Sasano, Hironobu; Suzuki, Takashi
err分享
err收藏
Multidisciplinary Treatment for Lymphorrhea and Chylorrhea Following Lymph Node Dissection for Genitourinary Cancer泌尿生殖系统癌症淋巴结清扫术后淋巴漏和乳糜漏的多学科治疗
errCANCERS
IF4.4
err2025-02-10
err0
errOAAI
errKamiya, Naoto; Noro, Takahide; Okazaki, Taro; Ishitsuka, Naoki; Suzuki, Yuta; Iijima, Shota; Sugizaki, Yuka; Somoto, Takatoshi; Oka, Ryo; Utsumi, Takanobu; Endo, Takumi; Kasuya, Shusuke; Hiruta, Nobuyuki; Suzuki, Hiroyoshi
err分享
err收藏
Prespecified interim analysis of the DARolutamide ObservationaL (DAROL) study in Black/African American patients with nonmetastatic castration-resistant prostate cancer (nmCRPC)
err2024-09-21
err0
PREAI
errYu, Evan Y.; Pieczonka, Christopher; Suzuki, Hiroyoshi; Briganti, Alberto; Luz, Murilo; Murphy, Declan; Adorjan, Patrick; Ghadessi, Mercedeh; Verholen, Frank; Armstrong, Andrew J.
err分享
err收藏
THIRD INTERIM ANALYSIS (IA3) OF THE DAROLUTAMIDE OBSERVATIONAL (DAROL) STUDY IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC)
err2024-05-01
err0
PREAI
errGotto, Geoffrey; Suzuki, Hiroyoshi; Luz, Murilo; Briganti, Alberto; Yu, Evan Y.; Pieczonka, Christopher; Murphy, Declan; Malone, Ryan; Hamilton, Joelle; Chan, Jonathan E.; Sieber, Paul; Given, Robert W.; Adorjan, Patrick; Ghadessi, Mercedeh; Verholen, Frank; Armstrong, Andrew J.
err分享
err收藏
Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UK
err2023-08-11
err4
errOAAI
errGonzalez, Juan Marcos; Ganguli, Arijit; Morgans, Alicia K. K.; Tombal, Bertrand F. F.; Hotte, Sebastien J. J.; Suzuki, Hiroyoshi; Bhadauria, Hemant; Oh, Mok; Scales Jr, Charles D. D.; Wallace, Matthew J. J.; Yang, Jui-Chen; George, Daniel J. J.
err分享
err收藏